Genprex, Inc (GNPX) Stock Price

3.685 ▼ -0.355 (-8.79%)
Open: 4.27 Vol: 0 Day's range: 3.34 - 4.27 Nov 18, 15:59 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
GNPX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 3.68▲ 3.68▲ 3.59▲ 4.18▼ 5.54▼
MA10 3.66▲ 3.57▲ 3.74▼ 4.37▼ 2.89▲
MA20 3.58▲ 3.77▼ 4.01▼ 5.89▼ 1.56▲
MA50 3.70▼ 4.09▼ 4.11▼ 2.74▲ 0.89▲
MA100 3.99▼ 4.28▼ 4.88▼ 1.48▲ 1.85▲
MA200 4.10▼ 5.74▼ 4.33▼ 0.90▲ 24.67▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.025▲ 0.018▲ -0.035▼ -0.402▼ 0.441▲
RSI 54.741▲ 41.469▼ 38.311▼ 46.580▼ 57.619▲
STOCH 72.264     63.965     23.832     13.994▼ 38.892    
WILL %R -20.588▲ -62.903     -64.975     -89.942▼ -72.369    
CCI 84.687     23.522     -52.346     -101.932▼ 45.803    
Latest Filters Detected On GNPX
▲ GAP $GNPX Open Gap Up %5 Set Alert
▲ GAP $GNPX Open Gap Up %3 Set Alert
▲ GAP $GNPX Open Gap Up %2 Set Alert
▼ BREAK $GNPX Price Breaks 20 Days Low Set Alert
▼ BREAK $GNPX Price Breaks 10 Days Low Set Alert
Genprex, Inc News
Genprex, Inc.: Genprex Announces U.S. Patent for Reqorsa Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
Tuesday, November 18, 2025 06:10 AM
Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ ...
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
Tuesday, November 18, 2025 04:13 AM
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
Genprex Announces European Patent Office's Intent to Grant a Patent for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
Tuesday, November 04, 2025 11:10 PM
("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the ...
GNPX historical stock data
date open high low close volume
18/11/25 4.27 4.27 3.34 3.685 992,149
17/11/25 4.43 4.4886 3.946 4.04 215,902
14/11/25 4.07 4.49 3.97 4.43 207,531
13/11/25 4.60 4.6891 4.05 4.14 289,317
12/11/25 4.15 5.00 4.0201 4.60 770,764
11/11/25 3.92 4.07 3.90 4.05 206,568
10/11/25 4.37 4.58 3.90 4.00 243,325
07/11/25 4.71 4.755 4.16 4.21 230,577
06/11/25 5.96 6.30 4.60 4.69 416,301
05/11/25 4.61 6.25 4.60 5.85 497,059
Quote Details
52wk Low:0.14
52wk High:12.97
Vol:0
Avg Vol(3m):514.7M
1Y Chng:+247.64%
1M Chng:+1,408.39%
Add to Watch List
More Information
Index US Composite
Market Cap. 6.76M